MSN and breast carcinoma: MSN was significantly overexpressed in ADR-resistant breast cancer cells, MDA-MB-231/ADRr and MCF7/ADRr, compared to other drug-resistant cell lines (Fig. 6G and Supplementary Fig. 6G).